Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Syndecan binding protein pseudogene 3 (SDCBPP3) is classified as a pseudogene in the human genome and does not produce a functional protein. It is named for its sequence similarity to the gene encoding syndecan binding protein (syntenin, SDCBP), a bona fide adaptor protein involved in cell signaling and membrane trafficking. However, unlike the protein-coding SDCBP gene, SDCBPP3 does not have known biological roles, does not serve as a receptor, and is not implicated in disease or drug targeting. There is no current evidence connecting SDCBPP3 to functional protein expression or therapeutic processes[1][2]. Key distinctions: - SDCBPP3 is a *pseudogene* and not a functional protein, enzyme, receptor, or drug target[1][2]. - It has *no known biological, physiological, or pharmacological role* and is not used as a therapeutic or diagnostic target. SDCBP (syntenin), in contrast, is a functional protein-coding gene with several biological roles and is sometimes studied in the context of cancer and signaling pathways[5][7][9]. However, SDCBPP3 is distinct and does not code for this protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Syndecan binding protein pseudogene 3 (SDCBPP3).